Merck & Co., Inc. (MRK)
142.38
-0.41
(-0.29%)
USD |
NYSE |
Oct 08, 16:00
141.98
-0.40
(-0.28%)
Pre-Market: 06:07
Merck Cash from Operations (Quarterly) : 5.37B for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.37B |
| March 31, 2026 | 3.918B |
| December 31, 2025 | 2.857B |
| September 30, 2025 | 7.822B |
| June 30, 2025 | 3.293B |
| March 31, 2025 | 2.50B |
| December 31, 2024 | 3.45B |
| September 30, 2024 | 9.291B |
| June 30, 2024 | 5.637B |
| March 31, 2024 | 3.09B |
| December 31, 2023 | 246.00M |
| September 30, 2023 | 7.717B |
| June 30, 2023 | 3.704B |
| March 31, 2023 | 1.339B |
| December 31, 2022 | 4.43B |
| September 30, 2022 | 5.602B |
| June 30, 2022 | 4.302B |
| March 31, 2022 | 4.761B |
| December 31, 2021 | 5.031B |
| September 30, 2021 | 4.797B |
| June 30, 2021 | 2.49B |
| March 31, 2021 | 1.791B |
| December 31, 2020 | 4.006B |
| September 30, 2020 | 2.173B |
| June 30, 2020 | 3.367B |
| Date | Value |
|---|---|
| March 31, 2020 | 707.00M |
| December 31, 2019 | 4.794B |
| September 30, 2019 | 4.226B |
| June 30, 2019 | 3.084B |
| March 31, 2019 | 1.336B |
| December 31, 2018 | 3.592B |
| September 30, 2018 | 2.793B |
| June 30, 2018 | 3.382B |
| March 31, 2018 | 1.155B |
| December 31, 2017 | 4.019B |
| September 30, 2017 | -1.171B |
| June 30, 2017 | 3.317B |
| March 31, 2017 | 286.00M |
| December 31, 2016 | 3.632B |
| September 30, 2016 | 2.971B |
| June 30, 2016 | 1.615B |
| March 31, 2016 | 2.158B |
| December 31, 2015 | 4.247B |
| September 30, 2015 | 3.305B |
| June 30, 2015 | 2.585B |
| March 31, 2015 | 2.284B |
| December 31, 2014 | -1.164B |
| September 30, 2014 | 4.348B |
| June 30, 2014 | 2.315B |
| March 31, 2014 | 2.361B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Johnson & Johnson | 8.616B |
| Eli Lilly & Co. | 10.69B |
| Pfizer Inc. | 835.00M |
| Bristol Myers Squibb Co. | 3.393B |
| Viatris, Inc. | 381.80M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -5.602B |
| Cash from Financing (Quarterly) | 1.762B |
| Free Cash Flow | 16.06B |
| Free Cash Flow Per Share (Quarterly) | 1.813 |
| Free Cash Flow to Equity (Quarterly) | -312.00M |
| Free Cash Flow to Firm (Quarterly) | 5.505B |
| Free Cash Flow Yield | 4.55% |